Delstrigo 100 mg/300 mg/245 mg film-coated tablets
- Name:
Delstrigo 100 mg/300 mg/245 mg film-coated tablets
- Company:
MSD Ireland (Human Health) Limited
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 27/09/19

Click on this link to Download PDF directly
MSD Ireland (Human Health) Limited

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 13 July 2020 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 10 - Date of revision of the text
- Correction of spelling/typing errors
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Update to section 4.8 of the SmPC to implement the wording concerning “lactic acidosis” agreed by the PRAC following to the outcome of the PSUR Procedure
Updated on 3 January 2020 SPC
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
SPC - Update to 96 weeks resistance data table + QRD version 10.1
Updated on 27 September 2019 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Type IB PRAC Autoimmune Hepatitis
Updated on 27 September 2019 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
Change to section 2 – What you need to know – warnings and precautions
Change to section 6 – Revision Date
Updated on 20 May 2019 SPC
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Change to section 5.1 - Pharmacodynamic properties
Change to section 10 - Date of revision of the text
Addition of 96 weeks data P018 P021
Updated on 10 May 2019 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 10 May 2019 SPC
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Change to section 10 - Date of revision of the text
Updated on 29 April 2019 PIL
Reasons for updating
- New PIL for new product
Updated on 29 April 2019 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
New SPC for new product